Ataluren (formerly known as PTC 124; PTC-124; PTC124; trade name Translarna) is a novel, potent and orally bioavailable CFTR-G542X nonsense allele inhibitor that has been approved as a medication for the treatment of Duchenne muscular dystrophy.

GSK-7975A is a novel, potent and orally bioavailable inhibitor of CRAC (calcium release-activated calcium modulator).

Loteprednol etabonate (Lotemax; Alrex; HGP-1; Loterox; Locort; P-5604; HGP1; Lenoxin, CDDD-5604), the esther form of Loteprednol, is a potent glucocorticoid receptor agonist approved as a medication used in treatment of inflammation of the eye due to allergies.

Diltiazem ((Tiazac; CRD-401; Dilticard; RG83606) is a nondihydropyridines (non-DHP) calcium channel blocker with vasodilating activity.

AMG 517 (AMG-517; AMG517) is a novel, potent and selective TRPV1 (vanilloid receptor-1) antagonist with potential anti-inflammatory activity.

DHBP dibromide (Diheptylviologen dibromide) is a potent inhibitor for calcium release and a muscle relaxant.

Betamethasone Valerate (BV; BET; Betoid; Valison; 9α-Fluo; Valisone; Bedermin; Betneval; Beta-Val; Bextasol; Dermosol; Stanoval) is a moderately potent and commonly used glucocorticoid steroid with anti-inflammatory and immunosuppressive activities.

Amlodipine (formerly UK48340; trade name Norvasc among others), a marketed antihypertensive drug, is a long-acting L-type calcium channel blocker/CCB of the dihydropyridine/DHP class.

Fluspirilene (R 6218; Redeptin), a dopamine inhibitor and calcium channel protein inhibitor, is a diphenylbutylpiperidine typical antipsychotic drug, used for the treatment of schizophrenia.

Nicardipine HCl (formerly YC-93, RS-69216; YC93; trade names Cardene, Dagan, Antagonil, Flusemide), the hydrochloride salt of nicardipine, is a dihydropyridine/DHP class of calcium-channel blocker (CCB) with anti-hypertensive activity.